Varicella-zoster and herpes simplex virus reactivation post-COVID-19 vaccination: a review of 40 cases in an International Dermatology Registry
J Eur Acad Dermatol Venereol
.
2022 Jan;36(1):e6-e9.
doi: 10.1111/jdv.17646.
Epub 2021 Oct 5.
Authors
R A Fathy
1
,
D E McMahon
2
,
C Lee
3
,
G C Chamberlin
4
,
M Rosenbach
1
,
J B Lipoff
1
,
A Tyagi
4
,
S R Desai
5
6
,
L E French
7
8
,
H W Lim
9
,
B H Thiers
10
,
G J Hruza
11
,
M Fassett
12
,
L P Fox
12
,
H L Greenberg
13
,
K Blumenthal
2
,
E E Freeman
2
4
Affiliations
1
Department of Dermatology, University of Pennsylvania, Philadelphia, PA, USA.
2
Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.
3
Department of Dermatology, Las Vegas School of Medicine, University of Nevada, Las Vegas, NV, USA.
4
Medical Practice Evaluation Center, Mongan Institute, Massachusetts General Hospital, Boston, MA, USA.
5
The University of Texas Southwestern Medical Center, Dallas, TX, USA.
6
Innovative Dermatology, Plano, TX, USA.
7
Department of Dermatology, University Hospital, Munich University of Ludwig Maximilian, Munich, Germany.
8
Dr. Philip Frost, Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.
9
Department of Dermatology, Henry Ford Health System, Detroit, MI, USA.
10
Department of Dermatology and Dermatologic Surgery, Medical University of SC, Charleston, SC, USA.
11
Department of Dermatology, St. Louis University, St. Louis, MO, USA.
12
Department of Dermatology, University of California San Francisco, San Francisco, CA, USA.
13
Las Vegas Dermatology, Las Vegas, NV, USA.
PMID:
34487581
PMCID:
PMC8656951
DOI:
10.1111/jdv.17646
No abstract available
Publication types
Letter
MeSH terms
COVID-19 Vaccines
COVID-19*
Chickenpox*
Dermatology*
Herpes Simplex*
Herpes Zoster* / prevention & control
Herpesvirus 3, Human
Humans
Registries
SARS-CoV-2
Simplexvirus
Vaccination
Substances
COVID-19 Vaccines
Grants and funding
International League of Dermatologic Societies